His scientific interests lie mostly in Osteoporosis, Internal medicine, Endocrinology, Bone density and Surgery. His Osteoporosis research is multidisciplinary, relying on both Bone remodeling and Urology. His work deals with themes such as Placebo and Cancellous bone, which intersect with Internal medicine.
His Endocrinology study incorporates themes from Calcium metabolism, Parathyroid hormone and Calcium. His research integrates issues of Genetics, Tibia, Anatomy, Biopsy and Genetic linkage in his study of Bone density. His Surgery study integrates concerns from other disciplines, such as Oral administration, Epidemiology and Risk factor.
His primary areas of study are Internal medicine, Osteoporosis, Endocrinology, Bone mineral and Genetics. His studies in Osteoporosis integrate themes in fields like Surgery, Bone remodeling and Urology. His research in Bone remodeling intersects with topics in Biopsy, Bisphosphonate and Osteoid.
As part of his studies on Endocrinology, he often connects relevant subjects like Parathyroid hormone. His Bone mineral research incorporates elements of Cortical bone and Dentistry. Robert R. Recker interconnects Anatomy and Cancellous bone in the investigation of issues within Bone density.
Robert R. Recker spends much of his time researching Internal medicine, Osteoporosis, Endocrinology, Bone mineral and Bone density. His studies link Mineralization with Internal medicine. His Osteoporosis research includes elements of Surgery and Urology.
Robert R. Recker has researched Endocrinology in several fields, including Iliac crest, Matrix, Osteoblast and Pyridinoline. The Bone mineral study combines topics in areas such as Bone tissue and Clinical endpoint. His Bone density research is multidisciplinary, incorporating perspectives in Body mass index, Cancellous bone, Cortical bone, Bone resorption and Femoral neck.
Robert R. Recker mostly deals with Internal medicine, Endocrinology, Osteoporosis, Bone density and Bone mineral. His Internal medicine research integrates issues from Promoter and CYP27A1. His Endocrinology research is multidisciplinary, incorporating elements of Biopsy, Parathyroid hormone, Mineralization and Osteoblast.
The concepts of his Osteoporosis study are interwoven with issues in Surgery and Zoledronic acid. Robert R. Recker combines subjects such as Body mass index, Cancellous bone, Urology, Immunology and Osteoid with his study of Bone density. His Bone mineral study combines topics from a wide range of disciplines, such as Sclerostin and Bone resorption.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee
A. Michael Parfitt;Marc K. Drezner;Francis H. Glorieux;John A. Kanis.
Journal of Bone and Mineral Research (2009)
Bone Histomorphometry : Standardization of Nomenclature, Symbols, and Units
A. M. Parfitt;M. K. Drezner;F. H. Glorieux;J. A. Kanis.
Journal of Bone and Mineral Research (1987)
Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis
Uri A. Liberman;Stuart R. Weiss;Johann Broll;Helmut W. Minne.
The New England Journal of Medicine (1995)
Standardized nomenclature, symbols, and units for bone histomorphometry: A 2012 update of the report of the ASBMR Histomorphometry Nomenclature Committee
David W Dempster;Juliet E Compston;Marc K Drezner;Francis H Glorieux.
Journal of Bone and Mineral Research (2013)
Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial
Joan M Lappe;Dianne Travers-Gustafson;K Michael Davies;Robert R Recker.
The American Journal of Clinical Nutrition (2007)
A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait.
Randall D. Little;John P. Carulli;Richard G. Del Mastro;Josée Dupuis.
American Journal of Human Genetics (2002)
Effects of oral ibandronate administered daily or intermittently on fracture risk in postmenopausal osteoporosis.
Charles H Chesnut;Arne Skag;Claus Christiansen;Robert Recker.
Journal of Bone and Mineral Research (2004)
Bone gain in young adult women.
Robert R. Recker;K. Michael Davies;Sharilyn M. Hinders;Robert P. Heaney.
JAMA (1992)
American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003.
Stephen F. Hodgson;Nelson B. Watts;John P. Bilezikian;Bart L. Clarke.
Endocrine Practice (2003)
Prevention of postmenopausal bone loss by a low-magnitude, high-frequency mechanical stimuli: a clinical trial assessing compliance, efficacy, and safety.
Clinton T. Rubin;Robert Recker;Diane Cullen;John Ryaby.
Journal of Bone and Mineral Research (2003)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Tulane University
Creighton University
Columbia University
Columbia University
Vanderbilt University Medical Center
University of Colorado Anschutz Medical Campus
Australian Catholic University
University of Liège
Fudan University
Inserm
University of Maryland, Baltimore County
University of North Carolina at Chapel Hill
Chinese Academy of Sciences
Autonomous University of Barcelona
Istanbul University
University of Delaware
Radboud University Nijmegen
McGill University
University of Pannonia
Children's Hospital of Philadelphia
University of Sydney
University of Potsdam
Miriam Hospital
Thomas Jefferson University
Harvard University
University of Wisconsin–Madison